Arthroscopy Association of North America Annual Meeting
Arthroscopy Association of North America Annual Meeting
May 04, 2019
1 min read

Fascia iliaca compartment blockade may decrease narcotic use, pain after hip arthroscopy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Blake M. Bodendorfer

ORLANDO — Preoperative fascia iliaca compartment blockade injection in routine hip arthroscopy led to a decrease in narcotic use and improvements in pain scores, according to results presented here.

Blake M. Bodendorfer, MD, and colleagues randomly assigned 74 patients undergoing unilateral hip arthroscopy for femoroacetabular impingement to receive either preoperative fascia iliaca compartment blockade or normal saline injection. Researchers assessed patients preoperatively with the modified Harris Hip Score. Researchers also collected information on narcotic use, the numeric pain rating scale score in the post-anesthesia care unit and for 6 weeks postoperatively, and the post-anesthesia care unit duration of stay.

“We saw the [post-anesthesia care unit] PACU length of stay was significantly reduced in the fascia iliaca compartment blockade group,” Bodendorfer said in his presentation at the Arthroscopy Association of North America Annual Meeting.

Bodendorfer also noted a decrease in intraoperative narcotic use in the study group, which was not statistically significant. However, he added there was a significant difference between the two groups in postoperative narcotic use.

“There was nearly a one-point difference in the numeric pain rating scale, which is not very significant as compared to our other endpoints,” Bodendorfer said. “We also saw a larger decrease in pain in the immediate postoperative period.” – by Casey Tingle



Bodendorfer BM, et al. Preoperative fasci iliaca compartment blockade for hip arthroscopy: A multicenter, prospective, randomized, controlled, and triple-blinded study. Presented at: Arthroscopy Association of North America Annual Meeting; May 2-4, 2019; Orlando.


Disclosure: Bodendorfer reports no relevant financial disclosures.